Efficacy

Phase 2a, AMP Challenge, Dose Escalation Study to Assess the Dose Response for Topical Efficacy and Systemic Activity in Asthmatic Subjects

Condition:   AsthmaInterventions:   Drug: Fluticasone furoate (FF) Dry Powder Inhaler;   Drug: Fluticasone propionate (FP) Dry Powder Inhaler;   Drug: Budesonide (BUD) Turbuhaler;   Drug: Placebo (ELLIPTA or DISKUS)Sponsor:   GlaxoSmithKlineNot yet recruiting – verified December 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With Asthma

Condition:   AsthmaInterventions:   Drug: Indacaterol acetate 75 ?g;   Drug: Indacaterol acetate 150 ?gSponsor:   Novartis PharmaceuticalsNot yet recruiting – verified August 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES)

Condition:   Hypereosinophilic SyndromeInterventions:   Drug: Mepolizumab 300 mg;   Drug: Placebo matching mepolizumab;   Drug: Active OCS capsules (5 mg prednisolone or prednisone);   Drug: Placebo matching OCS capsulesSponsor:   GlaxoSmithKlineNot yet recruiting – verified July 2016 View full post on ClinicalTrials.gov: asthma | Studies received in the last 14…

Study of Safety and Efficacy of Mometasone Furoate Used in Combination With Formoterol Fumarate Compared With Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)

Condition:   AsthmaInterventions:   Drug: MK-0887A 100/10 mcg;   Drug: MK-0887 100 mcg;   Drug: Albuterol/Salbutamol;   Drug: Prednisone/PrednisoloneSponsor:   Merck Sharp & Dohme Corp.Not yet recruiting – verified April 2016 View full post on ClinicalTrials.gov: asthma | received in the last 14 days